Cookies?
Library Header Image
LSE Research Online LSE Library Services

Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting

Cowie, Martin R., Cure, Sandrine, Bianic, Florence, McGuire, Alistair, Goodall, Gordon and Tavazzi, Luigi (2011) Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting. European Journal of Heart Failure, 13 (6). pp. 681-689. ISSN 1388-9842

Full text not available from this repository.

Abstract

Aims A recent randomized placebo-controlled clinical trial has reported reductions in mortality and hospitalizations in patients with chronic heart failure (CHF) who were prescribed highly purified omega-3 polyunsaturated fatty acid ethyl esters (n-3 PUFA). This study aimed at evaluating the cost and benefits associated with their use in the treatment of CHF in a UK setting. Methods and results Results from a recent clinical trial were used to develop a Markov model to project clinical outcomes while capturing relevant costs and patient quality of life. The model captured outcomes over a lifetime horizon from a UK National Health Service perspective, with direct costs accounted in 2009 GBP ((sic)) and discounted at 3.5% together with clinical benefits. Results are presented in terms of life expectancy, quality-adjusted life expectancy, direct costs, and incremental cost-effectiveness ratios. In addition to standard therapy, n-3 PUFA vs. placebo increased lifetime direct costs by (sic) 993 (approximate to E1150), with additional quality-adjusted life expectancy of 0.079 quality-adjusted life years (QALYs), and mean lifetime costs of (sic)12 636 (approximate to(sic)E14 600) per QALY gained. Probabilistic sensitivity analyses suggested a 60% likelihood of n-3 PUFA being regarded as cost-effective versus placebo at a willingness-to-pay threshold of (sic)30 000 (approximate to E34 600) per QALY gained.

Item Type: Article
Official URL: http://eurjhf.oxfordjournals.org/
Additional Information: © 2011 European Society of Cardiology
Library of Congress subject classification: R Medicine > RA Public aspects of medicine
Sets: Departments > Social Policy
Research centres and groups > LSE Health
Rights: http://www.lse.ac.uk/library/usingTheLibrary/academicSupport/OA/depositYourResearch.aspx
Date Deposited: 29 Jun 2011 14:01
URL: http://eprints.lse.ac.uk/37027/

Actions (login required)

Record administration - authorised staff only Record administration - authorised staff only